Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03370562 · ClinicalTrials.gov registry record · NA
Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03370562 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT03370562, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a randomized double blinded trial to determine if a small dose of dexmedetomidine can prevent and relieve nausea and shivering, two of the more common complaints after cesarean delivery.
Interventions
- DRUG Placebo
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03370562
The ClinicalTrials.gov registry entry for NCT03370562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03370562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03370562 about?
NCT03370562 is a clinical study titled "Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering". This is a randomized double blinded trial to determine if a small dose of dexmedetomidine can prevent and relieve nausea and shivering, two of the more common complaints after cesarean delivery.
What is the current status of trial NCT03370562?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-02-18. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03370562?
The interventions under investigation include: Placebo (DRUG), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT03370562?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.